Skip to content
Insider tapeFilings through Fri, Nov 13
My stocks

R. Carter Pate

At a glance: R. Carter Pate is Director at Option Care Health (OPCH). Their latest SEC Form 4, filed Nov 12, 2026, reported a sale of $193K. On file: 0 purchase lines ($0) and 3 sale lines ($1.2M).

Disclosed holdings: about $447K of OPCH stock: 14,128 shares reported on their latest Form 4 (filed Nov 12, 2026), valued at the Nov 13, 2026 close of $31.65. This counts only OPCH shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Option Care Health, Inc. (OPCH)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.2M

Every purchase since 2021

From the SEC's insider data sets: each open-market buy by R. Carter Pate, matched to how the stock did over the next 90 days against the S&P 500.

1 of 4 buys beat the S&P 500 (25%), median -12.2% vs. the index. Small sample: treat with care. All insider buys: 46%.

StockFiled90 days vs. S&P 500
OPCHAug 21, 2025-4.8%
OPCHAug 21, 2023-19.6%
PRPLMay 17, 2023-40.9%
OPCHMay 20, 2021+14.0%

Buys made close together in one stock count once. Price-only returns; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 12SEC OPCHOption Care Health, Inc. Sell 6,09214,528 held (−30%) $31.65 $193K +0.0%
Nov 12SEC OPCHOption Care Health, Inc. Sell 40014,128 held (−3%) $31.65 $13K +0.0%
Mar 3SEC OPCHOption Care Health, Inc. Sell 30,28711,623 held (−72%) $32.05 $971K -1.2%
  • Sell

    Director R Carter Pate sold $193K of OPCH at $31.65 — cuts the stake by 30%.

  • Sell

    Director R Carter Pate sold $971K of OPCH at $32.05 — cuts the stake by 72%.

Follow R. Carter Pate

Get one email when R. Carter Pate files a new purchase or sale. Free.

At most one email a day about R. Carter Pate, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.